Published in Lab Law Weekly, May 25th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Oscient Pharmaceuticals Corporation.
Report 1: Oscient Pharmaceuticals Corporation (Nasdaq: OSCI) announced that it has commenced offers to exchange up to $185,600,000 aggregate principal amount of its new 3.50% Convertible Senior Notes due 2011 for up to all of the $152,750,000 aggregate principal amount of its currently outstanding 3 1/2% Senior Convertible Notes due 2011 and up to all of the $22,310,000 aggregate principal amount of its currently outstanding 5%...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.